USANA Health Sciences Insider Dave Wentz Sells 5,301 Shares (USNA)
USANA Health Sciences (NASDAQ:USNA) Insider Dave Wentz unloaded 5,301 shares of the company’s stock on the open market in a transaction dated Friday, June 13th. The stock was sold at an average price of $75.51, for a total value of $400,278.51. Following the transaction, the insider now directly owns 473,955 shares of the company’s stock, valued at approximately $35,788,342. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
USANA Health Sciences (NASDAQ:USNA) traded up 0.85% during mid-day trading on Friday, hitting $76.08. The stock had a trading volume of 136,066 shares. USANA Health Sciences has a one year low of $55.01 and a one year high of $92.00. The stock has a 50-day moving average of $72.34 and a 200-day moving average of $72.23. The company has a market cap of $1.059 billion and a P/E ratio of 13.90.
USANA Health Sciences (NASDAQ:USNA) last released its earnings data on Tuesday, April 29th. The company reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.30 by $0.15. The company had revenue of $182.40 million for the quarter, compared to the consensus estimate of $185.85 million. During the same quarter in the previous year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, analysts predict that USANA Health Sciences will post $5.66 earnings per share for the current fiscal year.
Separately, analysts at Zacks downgraded shares of USANA Health Sciences from an “outperform” rating to a “neutral” rating in a research note on Tuesday, April 8th. They now have a $79.50 price target on the stock. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. USANA Health Sciences presently has an average rating of “Hold” and an average target price of $79.38.
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.